Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Nuvasive Inc (NUVA) Com Stk USD0.001

Sell:$54.45 Buy:$60.22 Change: $0.30 (0.53%)
NASDAQ:0.52%
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
Sell:$54.45
Buy:$60.22
Change: $0.30 (0.53%)
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
Sell:$54.45
Buy:$60.22
Change: $0.30 (0.53%)
Market closed |  Prices as at close on 2 July 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

Contact details

Address:
7475 Lusk Blvd
SAN DIEGO
92121-5707
United States
Telephone:
+1 (858) 9091800
Website:
https://www.nuvasive.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NUVA
ISIN:
US6707041058
Market cap:
$2.91 billion
Shares in issue:
51.25 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Gregory Lucier
    Chairman of the Board
  • Matthew Link
    President
  • J. Christopher Barry
    Chief Executive Officer, Director
  • Matthew Harbaugh
    Executive Vice President, Chief Financial Officer
  • Lucas Vitale
    Chief Human Resource Officer
  • Nathaniel Sisitsky
    Senior Vice President, General Counsel, Corporate Secretary
  • Dale Wolf
    Senior Vice President - Global Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.